NCAM1 and Alzheimer disease: The addition of Aβ peptide 1–42 to our human NPCs culture model, generates results that are similar to those obtained in human AD samples regarding the expression of the NCAM1, TUBB3, and RBFOX3 genes, offering an in vitro opportunity to study AHN impairment in the AD context.